CLASS II Drug recall · Reported 26 Mar 2014 · FDA Enforcement Report
Perrigo, Clindamycin Palmitate Hydrochloride recalled
Paddock Laboratories is recalling Perrigo, Clindamycin Palmitate Hydrochloride for Oral Solution, USP, 75mg, distributed nationwide in the US. The recall was initiated on 11 Mar 2014 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1168-2014
- FDA event ID
- 67735
- Recalling firm
- Paddock Laboratories, Minneapolis, MN
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 11 Mar 2014
- FDA classified
- 20 Mar 2014
- Reported
- 26 Mar 2014
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Particulate Matter
- Drug class
- Antibiotics
Timeline
| 11 Mar 2014 | Recall initiated by company | |
| 20 Mar 2014 | Classified by FDA | +9 days |
| 26 Mar 2014 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Presence of Particulate Matter Perrigo is recalling seven lots of Clindamycin Palmitate Hydrochloride for Oral Solution 75mg/5ml.
Product as listed by the FDA
Perrigo, Clindamycin Palmitate Hydrochloride for Oral Solution, USP, 75mg/5mL, 100 ml, NDC 0574-0129-01
Where it was distributed
Nationwide
Questions about this recall
Why was it recalled?
Presence of Particulate Matter Perrigo is recalling seven lots of Clindamycin Palmitate Hydrochloride for Oral Solution 75mg/5ml.
Which lots are affected?
2013313915 Exp 08/15, 2013374398 Exp 09/15, 2013323969 Exp 08/15, 2013364336 Exp 09/15, 2013323971 Exp 08/15, 2013364334 Exp 09/15, 2013313913 Exp 08/15
Where was it sold?
Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Paddock Laboratories
All 3| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Evamist (estradiol transdermal spray), 1.53mg estradiol/spray recalledEvamist | Paddock Laboratories | Packaging Defects | Nationwide |
| Drug | CLASS II | Moexipril HCl Tablets 7.5mg, 100 tabs recalled by Paddock Laboratories | Paddock Laboratories | Potency & Assay | Nationwide |